{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:07:45Z","timestamp":1788865665716,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006261","name":"Taif University","doi-asserted-by":"publisher","award":["TU-DSPP-2024-256"],"award-info":[{"award-number":["TU-DSPP-2024-256"]}],"id":[{"id":"10.13039\/501100006261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Saudi Pharm. J."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s44446-026-00104-z","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T07:53:50Z","timestamp":1786002830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A real-world, bottom-up cost of illness analysis of type 2 diabetes mellitus from a tertiary hospital in Saudi Arabia"],"prefix":"10.1007","volume":"34","author":[{"given":"Saleh","family":"Alyahya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Alhawwashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad Saeed","family":"Alqhatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ayoob","family":"Asseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmohsen Yahya","family":"Asseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bander","family":"Albalkhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1664-8779","authenticated-orcid":false,"given":"Abdullah Mohammed","family":"Al Shahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"3","key":"104_CR1","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s12325-023-02772-y","volume":"41","author":"M AlHarbi","year":"2024","unstructured":"AlHarbi M et al (2024) Burden of illness of type 2 diabetes mellitus in the Kingdom of Saudi Arabia: a five-year longitudinal study. Adv Ther 41(3):1120\u20131150","journal-title":"Adv Ther"},{"issue":"1","key":"104_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2230-8229.108174","volume":"20","author":"A Alhowaish","year":"2013","unstructured":"Alhowaish A (2013) Economic costs of diabetes in Saudi Arabia. J Fam Community Med 20(1):1\u20137","journal-title":"J Fam Community Med"},{"issue":"7","key":"104_CR3","first-page":"382","volume":"6","author":"MA Banerji","year":"2013","unstructured":"Banerji MA, Dunn JD (2013) Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes. Am Health Drug Benefits 6(7):382\u2013392","journal-title":"Am Health Drug Benefits"},{"key":"104_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/XCE.0000000000000116","volume":"6","author":"W Fan","year":"2017","unstructured":"Fan W (2017) Epidemiology in diabetes mellitus and cardiovascular disease. Cardiovasc Endocrinol 6:8\u201316","journal-title":"Cardiovasc Endocrinol"},{"key":"104_CR5","doi-asserted-by":"crossref","unstructured":"Kanan M et al (2024) The price of health: unveiling the cost of diabetes treatment in Kingdom of Saudi Arabia (KSA); a systematic literature review protocol. Pharmacy Practice 22(3)","DOI":"10.18549\/PharmPract.2024.3.2972"},{"key":"104_CR6","first-page":"722","volume":"66","author":"SA Meo","year":"2016","unstructured":"Meo SA (2016) Prevalence and future prediction of type 2 diabetes mellitus in the Kingdom of Saudi Arabia: A systematic review of published studies. J Pak Med Assoc 66:722\u2013725","journal-title":"J Pak Med Assoc"},{"key":"104_CR7","first-page":"575","volume":"6","author":"AH Mokdad","year":"2015","unstructured":"Mokdad AH et al (2015) Cost of diabetes in the Kingdom of Saudi Arabia, 2014. J Diabetes Metab 6:575","journal-title":"J Diabetes Metab"},{"issue":"4","key":"104_CR8","first-page":"435","volume":"27","author":"TV Newman","year":"2021","unstructured":"Newman TV et al (2021) Health care utilization and costs associated with switching from DPP-4i to GLP-1RA or SGLT2i: an observational cohort study. J Manag Care Spec Pharm 27(4):435\u2013443","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"104_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.diabres.2014.03.020","volume":"105","author":"CS Ng","year":"2014","unstructured":"Ng CS et al (2014) Cost-of-illness studies of diabetes mellitus: a systematic review. Diabetes Res Clin Pract 105(2):151\u2013163","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"104_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3122\/jabfm.2021.03.200361","volume":"34","author":"KW Rohatgi","year":"2021","unstructured":"Rohatgi KW, Humble S, McQueen A et al (2021) Medication adherence and characteristics of patients who spend less on basic needs to afford medications. J Am Board Fam Med 34(3):561\u2013570. https:\/\/doi.org\/10.3122\/jabfm.2021.03.200361","journal-title":"J Am Board Fam Med"},{"issue":"3","key":"104_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/jama.291.3.335","volume":"291","author":"SH Saydah","year":"2004","unstructured":"Saydah SH, Fradkin J, Cowie CC (2004) Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291(3):335\u2013342","journal-title":"JAMA"},{"key":"104_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.rce.2013.11.002","volume":"214","author":"A Sicras-Mainar","year":"2014","unstructured":"Sicras-Mainar A, Navarro-Artieda R, Ib\u00e1\u00f1ez-Nolla J (2014) Clinical and economic characteristics associated with type 2 diabetes mellitus. Rev Clin Esp 214:121\u2013130","journal-title":"Rev Clin Esp"},{"issue":"7258","key":"104_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321(7258):405\u2013412","journal-title":"BMJ"},{"issue":"1","key":"104_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12916-022-02427-9","volume":"20","author":"PB Tran","year":"2022","unstructured":"Tran PB et al (2022) Costs of multimorbidity: a systematic review and meta-analyses. BMC Med 20(1):234","journal-title":"BMC Med"},{"issue":"3","key":"104_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.diabres.2010.01.026","volume":"87","author":"P Zhang","year":"2010","unstructured":"Zhang P et al (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 87(3):293\u2013301","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"104_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.amepre.2013.04.017","volume":"45","author":"X Zhuo","year":"2013","unstructured":"Zhuo X, Zhang P, Hoerger TJ (2013) Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med 45(3):253\u2013261","journal-title":"Am J Prev Med"},{"issue":"5","key":"104_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2337\/dci18-0007","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association (2018) Economic costs of diabetes in the US in 2017. Diabetes Care 41(5):917\u2013928","journal-title":"Diabetes Care"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-026-00104-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44446-026-00104-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-026-00104-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:17:23Z","timestamp":1788862643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44446-026-00104-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["104"],"URL":"https:\/\/doi.org\/10.1007\/s44446-026-00104-z","relation":{},"ISSN":["1319-0164","2213-7475"],"issn-type":[{"value":"1319-0164","type":"print"},{"value":"2213-7475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical standards of the Armed Forces Hospital Southern Region. Ethical approval was obtained prior to data collection. All patient data were anonymized, and informed consent was waived due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"51"}}